- Report
- November 2024
- 269 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 262 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 167 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 413 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 326 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 193 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 299 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 164 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 383 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 172 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 146 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 164 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 344 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 283 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 182 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 186 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 380 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 273 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 284 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 191 Pages
Global
From €5531EUR$5,600USD£4,602GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more